Chen J N, Ho K Y, Juan K H
Department of Otorhinolarygology, Kaohsiung Medical College, Taiwan, Republic of China.
Kaohsiung J Med Sci. 1998 Aug;14(8):519-23.
A mitochondrial tRNA mutation at nucleotide 3,243 is known to be found in most patients with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes). We report a 30 year-old female patient of MELAS, diagnosed 5 years ago, who presented herself to our ENT outpatient department because of her bilateral tinnitus and progressive hearing impairment since 4 years ago. Two sequential pure tone audiograms showed bilateral symmetrical progressive sensorineural hearing loss, especially in the high frequency area in 1993 and 1996. The pure tone average was R-45 dB, L-47 dB in 1993 and R-62 dB, L-67 dB in 1996. Hearing loss is an important feature in MELAS syndrome and reported to be seen in about 30% of patients. It is often the first clinical symptom, too. In any case, mitochondrial cytopathies need to be considered by the otologist in forming a diagnosis of sensorineural hearing loss (SNHL), particularly in cases, which present adult-onset progressive hearing loss and neurologic symptoms before 50 years of age.
已知在大多数患有线粒体肌病、脑病、乳酸性酸中毒和卒中样发作(MELAS)的患者中,存在核苷酸3243处的线粒体tRNA突变。我们报告了一名30岁的MELAS女性患者,5年前被诊断出患有该病,她因自4年前起出现双侧耳鸣和进行性听力减退,前来我们的耳鼻喉科门诊就诊。1993年和1996年的两份连续纯音听力图显示双侧对称性进行性感音神经性听力损失,尤其是在高频区域。1993年的纯音平均听阈为右耳45分贝,左耳47分贝;1996年为右耳62分贝,左耳67分贝。听力损失是MELAS综合征的一个重要特征,据报道约30%的患者会出现。它通常也是首个临床症状。无论如何,耳鼻喉科医生在诊断感音神经性听力损失(SNHL)时,尤其是在出现成人起病的进行性听力损失且50岁前有神经症状的病例中,需要考虑线粒体细胞病。